(Q50728323)

18 March 2018

title

Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. (English)

1 reference

18 March 2018

1 reference

M R Green

1

1 reference

18 March 2018

G M Manikhas

2

1 reference

18 March 2018

S Orlov

3

1 reference

18 March 2018

B Afanasyev

4

1 reference

18 March 2018

A M Makhson

5

1 reference

18 March 2018

P Bhar

6

1 reference

18 March 2018

M J Hawkins

7

1 reference

18 March 2018

publication date

1 June 2006

1 reference

18 March 2018

published in

Annals of Oncology

1 reference

18 March 2018

volume

17

1 reference

18 March 2018

issue

8

1 reference

18 March 2018

page(s)

1263-1268

1 reference

18 March 2018

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

Hypersensitivity reactions from taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

SPARC Inhibits Epithelial Cell Proliferation in Part through Stimulation of the Transforming Growth Factor-β–Signaling System

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL104

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDL104

1 reference

18 March 2018

PubMed ID

16740598

1 reference

18 March 2018